Associated Papers
Early-Onset Sarcoma With Germline MAX Variant: Expanding the Spectrum in Hereditary Pheochromocytoma and Paraganglioma.
Eren A et al.
Jcem Case Reports, 2025
Genotype and clinical phenotype characteristics of MAX germline mutation-associated pheochromocytoma/paraganglioma syndrome.
Lian B et al.
Frontiers in Endocrinology, 2024
Bilateral Pheochromocytoma with Germline MAX Variant without Family History.
Hata S et al.
Clinics and Practice, 2022
35645312 (PubMed )
Supplement: clinpract-12-00035-s001.zip › clinpract-1702561-supplementary.pdf
A Novel, Likely Pathogenic MAX Germline Variant in a Patient With Unilateral Pheochromocytoma.
Lam-Chung CE et al.
Journal of the Endocrine Society, 2021
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation.
Schaefer IM et al.
Nature Communications, 2017
Select a paper to view details